
Loading, please wait...

Loading, please wait...

The National Medical Commission (NMC) has announced a crucial extension for the submission of the Annual Disclosure Report by existing medical colleges. This report is essential for the annual renewal of MBBS seats. It applies to the Academic Year (AY) 2026-27. The new NMC Annual Disclosure deadline is now June 10, 2026.
Previously, the deadline for submitting the Annual Disclosure Report was May 30, 2026. However, the Undergraduate Medical Education Board (UGMEB) of the NMC observed many medical colleges had not yet submitted their reports. Several factors contributed to this. These included reported technical issues and requests for additional time from various institutions. Consequently, the Competent Authority granted a final extension. This ensures all colleges have the opportunity to comply.
All medical colleges and institutions holding a valid Letter of Permission (LoP) for the MBBS course must submit their Annual Disclosure Report. This must be done on the official NMC portal. This requirement is mandated by Regulation 4 of the Maintenance of Standards of Medical Education Regulations, 2023 (MSMER, 2023). Institutions must ensure they are registered with AEBAS to access the portal. Importantly, the information provided must be accurate and consistent across all NMC Boards. Submitted data cannot be edited post-submission.
Furthermore, medical colleges need to pay a mandatory fee of Rs. 3,54,000, inclusive of 18% GST. This payment must be made online via the portal’s payment gateway. No other payment methods will be accepted. Colleges can access the submission portal at https://application.nmc.org.in/.
The NMC has clearly stated that the extension to June 10, 2026, is a "final opportunity". Therefore, no further extensions will be granted under any circumstances. Colleges experiencing technical difficulties or needing further information should contact the helpdesk. The email for support is ug.helpdesk@nmc.org.in. It is advised that all stakeholders treat this matter with urgency. This will help avoid any issues with the annual renewal of MBBS seats.
For more details on medical education standards, refer to the official National Medical Commission website www.nmc.org.in. Additionally, you may find relevant internal content on previous NMC updates helpful.
Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Important regulatory update! The National Medical Commission (NMC) has extended the Annual Disclosure Report deadline for MBBS seat renewal to June 10, 2026...
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today